Prostate cancer is a major health concern for men. Rates of prostate cancer vary across the world, with some populations being at greater risk than others. Risk factors include age, race, and family history.
Viagra (sildenafil) is a medication used to treat erectile dysfunction. Sildenafil was originally developed as a cardiovascular drug, but it’s now most commonly used to treat erectile dysfunction. Viagra is a PDE5 inhibitor that works by increasing blood flow to the penis.
Emerging research is now exploring whether sildenafil could play a role in prostate cancer treatment and management. Some studies have looked at how sildenafil affects prostate cancer cells and tumor growth. Some research even suggests that sildenafil may have a synergistic effect when used with other cancer treatments.
This article will explore the complex relationship between Viagra and prostate cancer, covering potential benefits, risks, and mechanisms of action. As more research is performed, the future uses of Viagra may broaden to include cancer treatment.